Literature DB >> 3485543

The acid-stable proteinase inhibitor of human mucous secretions (HUSI-I, antileukoprotease). Complete amino acid sequence as revealed by protein and cDNA sequencing and structural homology to whey proteins and Red Sea turtle proteinase inhibitor.

U Seemüller, M Arnhold, H Fritz, K Wiedenmann, W Machleidt, R Heinzel, H Appelhans, H G Gassen, F Lottspeich.   

Abstract

The complete amino acid sequence of human antileukoprotease has been determined by direct sequencing of the inhibitory active protein isolated from seminal plasma (HUSI-I) and by sequence analysis of cDNA reverse-transcribed from mRNA prepared from cervical tissue. The inhibitor (Mr 11726) consists of 107 amino acid residues including 16 cysteines presumably forming disulfide bonds. The molecule comprises two consecutive domains which are homologous to each other, to the second domain of the basic protease inhibitor from Red Sea turtle (chelonianin) and to both domains of the whey proteins of rat and mouse. Both domains contain a pattern of cysteines known as the 'four-disulfide-core' that has also been found in wheat germ agglutinin and neurophysin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485543     DOI: 10.1016/0014-5793(86)81220-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  27 in total

1.  Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor.

Authors:  E Remold-O'Donnell; J Chin; M Alberts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

Review 2.  Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor.

Authors:  Stergios Doumas; Alexandros Kolokotronis; Panagiotis Stefanopoulos
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

3.  Expression of the secretory leukoprotease inhibitor gene in epithelial cells.

Authors:  T Abe; N Kobayashi; K Yoshimura; B C Trapnell; H Kim; R C Hubbard; M T Brewer; R C Thompson; R G Crystal
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

4.  Characterization of the ovine ortholog of secretory leukoprotease inhibitor.

Authors:  Thomas I Brown; Rohit Mistry; Robert Gray; Margaret Imrie; David D Collie; Jean-Michel Sallenave
Journal:  Mamm Genome       Date:  2005-09-14       Impact factor: 2.957

5.  Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteases.

Authors:  G Stetler; M T Brewer; R C Thompson
Journal:  Nucleic Acids Res       Date:  1986-10-24       Impact factor: 16.971

6.  Antibacterial activity of antileukoprotease.

Authors:  P S Hiemstra; R J Maassen; J Stolk; R Heinzel-Wieland; G J Steffens; J H Dijkman
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

7.  Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.

Authors:  C Vogelmeier; R C Hubbard; G A Fells; H P Schnebli; R C Thompson; H Fritz; R G Crystal
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

8.  Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.

Authors:  Sinéad Weldon; Paul McNally; Noel G McElvaney; J Stuart Elborn; Danny F McAuley; Julien Wartelle; Abderrazzaq Belaaouaj; Rodney L Levine; Clifford C Taggart
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

9.  eNAP-2, a novel cysteine-rich bactericidal peptide from equine leukocytes.

Authors:  M A Couto; S S Harwig; J S Cullor; J P Hughes; R I Lehrer
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

10.  Oxidized mucus proteinase inhibitor: a fairly potent neutrophil elastase inhibitor.

Authors:  C Boudier; J G Bieth
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.